Cite
HARVARD Citation
Monteil, V. et al. (2022). Clinical grade ACE2 as a universal agent to block SARS‐CoV‐2 variants. EMBO molecular medicine. 14 (8), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Monteil, V. et al. (2022). Clinical grade ACE2 as a universal agent to block SARS‐CoV‐2 variants. EMBO molecular medicine. 14 (8), p. n/a. [Online].